Loading
Loading
Roivant Sciences ceo salary
Eric Venker, President and Immunovant CEO of Roivant Sciences Ltd. (ROIV), received $24,400,210 ($24.4M) in total compensation for FY2025, up 106.7% from the prior year. Other compensation of $20,163,986 was the largest component. Figures come from Roivant Sciences Ltd.'s DEF 14A filed 29 Jul 2026 (accession 0001140361-26-029955).
Reported total from the latest DEF 14A pay table. Source filing (accession 0001140361-26-029955). These figures come from Roivant Sciences Ltd.'s DEF 14A filed 29 Jul 2026 (accession 0001140361-26-029955).
| Component | Amount |
|---|---|
| Salary | $75,000 |
| Stock awards | $2,261,908 |
| Other | $20,163,986 |
| Total | $24,400,210 |
FAQ
See also: ROIV ticker page